Aptuit LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aptuit LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3402
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aptuit LLC (Aptuit) is a developer and manufacturer of pharmaceutical drug. The company offers drug design and discovery, IND enabling programs, integrated chemistry, manufacture and control and indigo. It drug discovery capabilities includes medicinal chemistry, computational chemistry, pharmacology, translational pharmacology, microbiology, drug metabolism and pharmacokinetics, and analytical discovery support. Aptuit’s therapeutics area comprises therapeutic areas, neuroscience, antibacterial, oncology and respiratory. The company provides services such as compound management, computational chemistry, medicinal chemistry, analytical chemistry, NMR spectroscopy, scale-up chemistry, high thoughput screening, pharmacology, electrophysiology, microbiology, biomarkers, DMPK, compound phys chem properties and discovery toxicology. It serves pharmaceutical and biotechnology companies. The company operates in the US, Italy, Switzerland and the UK. Aptuit is headquartered in Greenwich, Connecticut, the US.

Aptuit LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aptuit LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aptuit LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aptuit LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bioversys and Aptuit Enter into Partnership 10
Dementia Discovery Fund and Aptuit Enter into Partnership 11
Aptuit Enters into Agreement with Massachusetts General Hospital 12
Chronos Therapeutics Partners with Aptuit 13
Aptuit Enters into Agreement with Chiesi Farmaceutici 14
Aptuit Enters into Agreement with Dimension Therapeutics 15
Icagen Partners with Aptuit 16
SAMDI Tech Enters into Agreement with Exquiron 17
Asset Transactions 18
Catalent Pharma Completes Acquisition Of Clinical Trial Supplies Business From Aptuit For US$410 Million 18
Acquisition 19
Evotec Acquires Aptuit for USD300 Million 19
Aptuit Acquires Kuecept 21
Aptuit Acquires Exquiron Biotech 22
Albany Molecular Research Acquires SSCI from Aptuit for USD36 Million 23
Albany Molecular Research Acquires Aptuit Glasgow from Aptuit for USD24 Million 24
Aptuit LLC – Key Competitors 25
Aptuit LLC – Key Employees 26
Aptuit LLC – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 27
Recent Developments 28
Corporate Communications 28
Apr 06, 2017: Aptuit Announces Alignment of Organizational Structure to Integrated Solution Delivery: Henning Steinhagen Appointed as President, Research and Development Operations 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Aptuit LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aptuit LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aptuit LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Aptuit LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bioversys and Aptuit Enter into Partnership 10
Dementia Discovery Fund and Aptuit Enter into Partnership 11
Aptuit Enters into Agreement with Massachusetts General Hospital 12
Chronos Therapeutics Partners with Aptuit 13
Aptuit Enters into Agreement with Chiesi Farmaceutici 14
Aptuit Enters into Agreement with Dimension Therapeutics 15
Icagen Partners with Aptuit 16
SAMDI Tech Enters into Agreement with Exquiron 17
Catalent Pharma Completes Acquisition Of Clinical Trial Supplies Business From Aptuit For US$410 Million 18
Evotec Acquires Aptuit for USD300 Million 19
Aptuit Acquires Kuecept 21
Aptuit Acquires Exquiron Biotech 22
Albany Molecular Research Acquires SSCI from Aptuit for USD36 Million 23
Albany Molecular Research Acquires Aptuit Glasgow from Aptuit for USD24 Million 24
Aptuit LLC, Key Competitors 25
Aptuit LLC, Key Employees 26
Aptuit LLC, Subsidiaries 27
Aptuit LLC, Joint Venture 27

List of Figures
Aptuit LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aptuit LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aptuit LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amplifon SpA (AMP):医療機器:M&Aディール及び事業提携情報
    Summary Amplifon SpA (Amplifon) is a medical device company, which provides customized hearing solutions and services. It distributes hearing aids and other audio and telephony solutions. The company also offers related services such as audiological assessment, education, counseling, customization a …
  • Dean Foods Co:企業のM&A・事業提携・投資動向
    Dean Foods Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dean Foods Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Seven Bank, Ltd.:企業の戦略・SWOT・財務情報
    Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tizona Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • Euskaltel SA (EKT):企業の財務・戦略的SWOT分析
    Euskaltel SA (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Constantinou Bros Hotels Ltd:企業の戦略・SWOT・財務情報
    Constantinou Bros Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Constantinou Bros Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Mitsubishi Logistics Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Logistics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Logistics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cape plc:企業の戦略・SWOT・財務情報
    Cape plc - Strategy, SWOT and Corporate Finance Report Summary Cape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Globeimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Midea Group Co Ltd
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aoyama Trading Co., Ltd.
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Yomeishu Seizo Co Ltd (2540):企業の財務・戦略的SWOT分析
    Yomeishu Seizo Co Ltd (2540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • e-Therapeutics Plc (ETX):企業の財務・戦略的SWOT分析
    e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Medimetriks Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medimetriks Pharmaceuticals Inc (MPI) is a drug company that offers skincare products. The company provides personal care products including cleansers, nutritional suppliments, cosmetic creams, and moisturizer. Its products include Centany, Ciclodan, Clindacin ETZ, Genadur, Ketodan, Morgidox …
  • Premaitha Health Plc (NIPT)-製薬・医療分野:企業M&A・提携分析
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Sinopharm Group Co Ltd (1099):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp is a distributor of pharmaceutical and healthcare products. The group provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceut …
  • Uranium Energy Corp:企業の戦略・SWOT・財務情報
    Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Boston Children’s Hospital:企業の戦略的SWOT分析
    Boston Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆